In situ cancer vaccination using lipidoid nanoparticles
Jinjin Chen(Sichuan University), Qiaobing Xu(Tufts University), Jianzhu Chen(Massachusetts Institute of Technology), Zhongfeng Ye(Tufts University), Xuewei Zhao(Tufts University), Min Qiu(Kunming Institute of Botany), Yamin Li(Tufts University), Liu Yang(Tufts University), Zachary Glass(Tufts University)
Cited by 117
Related Papers
New Approaches to Nanofabrication: Molding, Printing, and Other Techniques
|Chemical Reviews|2005|2k
Preparation of Monodisperse Biodegradable Polymer Microparticles Using a Microfluidic Flow‐Focusing Device for Controlled Drug Delivery
|Small|2009|588
Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents
|Nature|2017|547
Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis
|Proceedings of the National Academy of Sciences|2022|495
Lipid nanoparticle-mediated lymph node–targeting delivery of mRNA cancer vaccine elicits robust CD8 <sup>+</sup> T cell response
|Proceedings of the National Academy of Sciences|2022|411